학술논문

Two cases of systemic capillary leak syndrome associated with COVID-19 in Japan.
Document Type
Report
Author
Kosaka A; Department of Infectious Diseases, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan. Electronic address: kosakamedoffice@gmail.com.; Goto T; Department of Infectious Diseases, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.; Washino T; Department of Infectious Diseases, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.; Sakamoto N; Department of Infectious Diseases, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.; Iwabuchi S; Department of Infectious Diseases, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.; Nakamura-Uchiyama F; Department of Infectious Diseases, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
Source
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7780 (Electronic) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE
Subject
Language
English
Abstract
Systemic Capillary Leak Syndrome (SCLS) is a rare disease that causes severe distributive shock provoked by infection or vaccination. SCLS is clinically diagnosed by a triad of distributive shock, paradoxical hemoconcentration, and hypoalbuminemia. SCLS associated with coronavirus disease (COVID-19) in adults has not been reported yet in Japan. Case 1: A 61-year-old woman with fever, sore throat, headache, and muscle pain was admitted to our emergency department with suspected COVID-19. She had been diagnosed with SCLS 3 years earlier. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen and polymerase chain reaction (PCR) tests were negative at admission. She went into shock in the emergency department and was treated for septic shock. The following day, the SARS-CoV-2 PCR test was positive. She did not respond to fluid resuscitation and catecholamine and finally died. Case 2: A 58-year-old man was admitted to our hospital for de-saturation due to COVID-19. He got into shock on day 3. SCLS was suspected, and 5 g of intravenous immunoglobulin and 5% albumin were administered for sepsis treatment. He responded to the aggressive fluid therapy within 48 h and was finally discharged. COVID-19 can trigger SCLS, and early recognition of SCLS is crucial for survival. Primary care physicians should consider SCLS when they observe distributive shock and paradoxical hemoconcentration deviations from the natural course of COVID-19.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.)